The Malaysia Medical Device Contract Manufacturing Market was valued at $381.8 Million in 2025 and projected to reach to $640 Million by 2030, representing a compound annual growth rate of 10.9%. Malaysia's medical device contract manufacturing sector is poised for significant expansion, driven by increasing demand from multinational medical device companies seeking cost-effective outsourcing solutions without compromising quality.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Malaysia serves as a critical manufacturing hub for medical device contract manufacturers, leveraging its geographic proximity to major Asian markets and established supply chain networks that reduce lead times and operational costs.
The country boasts a well-trained workforce with expertise in precision manufacturing and quality control, supported by modern industrial parks and ISO-certified facilities that meet stringent international medical device standards.
Malaysia's medical device contract manufacturing market is expanding at a CAGR of 10.9%, growing from $381.8 million in 2025 to $640.0 million by 2030, driven by increasing outsourcing demand from global OEMs.
Malaysia maintains strong regulatory frameworks aligned with international standards (FDA, CE marking), making it an ideal destination for companies requiring compliant, certified contract manufacturing services.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | DRUG DELIVERY DEVICES (Device) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10.9% from 2025 to 2030 |
| Largest Segment | DEVICE DEVELOPMENT & MANUFACTURING SERVICES (Service) |
| Market Size Base Year (Billions) | ~USD 83.96 (2025) |
| Revenue Forecast (Billions) | ~USD 140.84 (2030) |
| Segments Covered | Device, Type, Device Class, Service |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| EIKEN CHEMICAL CO., LTD. | Japan | Public Company | Fecal immunochemical test (FIT) reagents for colorectal cancer screening,Microbiological reagents (media, antimicrobial susceptibility, rapid tests),Urinalysis test strips (occult blood, protein, glucose), |
| CYIENT | India | Public Company | Digital, Engineering & Technology,Design Led Manufacturing,Others (Networks, Operations, and Adjacent Services), |
| JABIL INC. | United States | ||
| FLEX LTD. | Singapore | Public Company | Integrated Technology Solutions (ITS),Regulated Manufacturing Solutions (RMS),Cloud and Power Infrastructure (CPI), |
| PLEXUS CORP. | United States | Public Company | Healthcare/Life Sciences EMS and Design Services,Aerospace/Defense EMS and Engineering,Industrial/Commercial EMS and Sustaining Services, |
| SANMINA CORPORATION | United States | Public Company | Integrated Manufacturing Solutions (design-to-delivery EMS),Components, Products and Services, |
| INTEGER HOLDINGS CORPORATION | United States | Public Company | Cardiac Rhythm Management & Heart Failure (devices, leads, power solutions),Neuromodulation (spinal cord stimulators and related components),Cardio & Vascular / Interventional (cardiology, structural heart, peripheral, neurovascular, oncology), |
| CELESTICA INC. | Canada | Public Company | Connectivity and Cloud Solutions,Advanced Technology Solutions, |
| WEST PHARMACEUTICAL SERVICES, INC. | United States | Public Company | Proprietary Products – stoppers, seals, syringe and cartridge components,Proprietary Products – drug containment systems, self-injection devices, and integrated services,Contract-Manufactured Products – devices and assemblies, |
| RECIPHARM AB | Sweden | Private Company | Advanced Delivery Systems (ADS – inhalation, devices, integrated drug–device),Manufacturing Steriles (MFG-S – injectables, lyophilisation, blow-fill-seal),Manufacturing Solids & Others (MFG-SO – tablets, capsules, semi-solids, liquids, powders), |
| KIMBALL ELECTRONICS, INC. | United States | Public Company | Automotive electronics and assemblies,Medical EMS and contract manufacturing (disposables, drug delivery),Industrial and other electronics manufacturing, |
| NORTECH SYSTEMS, INC. | United States | Public Company | Electromedical devices and imaging assemblies,Electromechanical and industrial systems/box builds,Wire and cable assemblies, |
| CARCLO PLC | United Kingdom | Public Company | In vitro diagnostics and medical consumables,Drug delivery components and assemblies,Aerospace and safety cables and systems, |
EIKEN CHEMICAL CO., LTD. is a Japanese public company founded in 1939 with 696 employees. The company operates in the chemical manufacturing sector.
CYIENT is an Indian public company founded in 1991 with 12,049 employees. The company provides engineering, design, and technology services across multiple industries.
Insufficient data provided for business description.
FLEX LTD. is a Singapore-based public company founded in 1969 with 149,686 employees. The company is a global electronics manufacturing services provider.
PLEXUS CORP. is a United States-based public company founded in 1979 with 20,000 employees. The company provides electronics manufacturing services and specialized solutions.
SANMINA CORPORATION is a United States-based public company founded in 1980 with 35,000 employees. The company is a global provider of electronics manufacturing services and supply chain solutions.
INTEGER HOLDINGS CORPORATION is a United States-based public company founded in 1970 with 11,000 employees. The company manufactures medical devices and components for the healthcare industry.
CELESTICA INC. is a Canadian public company founded in 1994 with 23,803 employees. The company provides electronics manufacturing services and supply chain solutions globally.
WEST PHARMACEUTICAL SERVICES, INC. is a United States-based public company founded in 1923 with 10,800 employees. The company manufactures packaging and delivery systems for the pharmaceutical and healthcare industries.
RECIPHARM AB is a Swedish private company founded in 1994 with 6,752 employees. The company provides pharmaceutical manufacturing and development services.
KIMBALL ELECTRONICS, INC. is a United States-based public company founded in 1961 with 5,700 employees. The company provides electronics manufacturing services and solutions.
NORTECH SYSTEMS, INC. is a United States-based public company founded in 1990 with 699 employees. The company provides electronics manufacturing and engineering services.
CARCLO PLC is a United Kingdom-based public company founded in 1924 with 907 employees. The company manufactures precision-engineered components and assemblies for various industries.
Malaysia's medical device contract manufacturing market is valued at $381.8 million in 2025 and is expected to grow to $640.0 million by 2030.
Malaysia's medical device contract manufacturing market is projected to grow at a compound annual growth rate (CAGR) of 10.9% from 2025 to 2030.
Malaysia offers strategic geographic positioning within Asia Pacific, established regulatory frameworks, a skilled workforce, competitive cost structures, and proximity to key regional markets, making it ideal for contract manufacturing outsourcing.
Growth drivers include rising healthcare expenditures across Asia Pacific, increasing demand for cost-effective outsourcing solutions, investments in advanced manufacturing technologies, and expanding quality certifications in Malaysia.
Malaysia represents a significant segment within Asia Pacific's medical device contract manufacturing market, leveraging its established infrastructure and regulatory environment to compete effectively for regional and global outsourcing opportunities.
The study involved four key activities to estimate the current size of the medical device contract manufacturing market. Extensive secondary research was conducted to gather information on the market, peer markets, and parent market. The next step was to validate these findings, assumptions, and estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to calculate the total market size. Then, market segmentation and data triangulation were applied to determine the size of segments and subsegments.
The secondary research process involved extensively utilizing secondary sources such as directories, databases (like Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. This research was used to gather information essential for the detailed, technical, market-oriented, and commercial analysis of the medical device contract manufacturing market. It also helped obtain critical information about key players, market classification, and segmentation based on industry trends down to the most detailed level, as well as key developments related to market and technology perspectives. Additionally, a database of leading industry players was created using secondary research.
During the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from several companies and organizations operating in the medical device contract manufacturing market. The primary sources from the demand side consist of industry experts, purchase and sales managers, doctors, and personnel from research organizations. Primary research was carried out to validate the market segmentation, identify key players, and gather insights on important industry trends and market dynamics.
A breakdown of the primary respondents for the medical device contract manufacturing market is provided below:
Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Other primaries include Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
The research methodology used to estimate the size of the medical device contract manufacturing market includes the following details. The market sizing was undertaken from a global perspective.
Country-level Analysis: The size of the medical device contract manufacturing market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall medical device contract manufacturing market was obtained from secondary data and validated by primary participants to arrive at the total medical device contract manufacturing market. Primary participants further validated the numbers.
Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each stage, assumptions and approaches were verified through industry experts contacted during primary research. Due to limitations in the data available from secondary research, revenue estimates for individual companies (covering the overall medical device contract manufacturing market and regional assessments) were determined based on a detailed analysis of their product offerings, geographic reach or strength (either directly or through distributors or suppliers), and the market shares of leading players in specific regions or countries.

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Medical device contract manufacturing involves a manufacturing company producing medical devices or components that other companies can later sell. These contract manufacturers specialize in specific processes or tasks and provide expertise through their regular manufacturing experience.
Full forecast, segment splits, and company analysis for all Medical Device Contract Manufacturing Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report